Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Refining and testing the electronic Social Network Assessment Program (eSNAP)
Functional Study of Native and Synthetic Nuclei
Retroviral Etiology of Primary Biliary Cirrhosis
Minority High School Student Research Apprentice Pregram
The Impacts of the "Right to Know": Information Disclosure and Drinking Water Quality
Recently added grants:
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs
Developing CRISPR genome editing technology for Entamoeba
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies
Genomic and epigenomic investigations of the transcriptional regulatory network of skin keratinocytes in defined genetic models
Laser Treatment Modality for Strengthening Osteoarthritic Cartilage
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07155-16-0-1
Application #
7574917
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ St. Jude Children's Research Hospital
$456,619
NIH 2007
N01 HL
Pedriatric Hydroxyurea Phase III Clinical Trial Clinical
Wang, Winfred C. /
$496,007
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant